Question Bank › Correcting the record with current facts

Correcting the record with current facts

Correcting the record with current facts: management is actively updating an out-of-date external picture of the company

Calls Tested
456
Answered YES
22
Hit Rate
4.8%
rare by design

Surgery Partners, Inc. (SGRY) — this company's answers

NO on the Q2 2022 call 2022-08-02 B+
The model's full reasoning — Q2 2022 call → NOWe need to determine if management identifies a stale or mistaken external view and corrects it with current, concrete facts. Looking at the transcript, management discusses various topics: results, inflation, M&A, recruiting, etc. They mention that the business model is durable, that they are managing inflation, that volumes are near normalized levels. They also discuss the shift of procedures to outpatient settings, and their growth in orthopedics and cardiac. Do they explicitly or implicitly indicate that outsiders hold an outdated or mistaken view? They mention that they are "not immune" to challenges but the model demonstrates durability. They talk about the market perhaps not recognizing the value of their model? They say "we believe we have a competitive advantage" and "our business model continues to demonstrate its durability and resiliency." But is that a correction of a stale view? They don't explicitly say "investors think X but actually Y." They do mention that they are "agnostic to the accounting treatment" of acquisitions, which might be a subtle pushback on how investors view their M&A. But that's not a clear identification of a mistaken external picture. They also talk about the transition of procedures out of acute care, and that they are well positioned. But that's more of a forward-looking opportunity. The question asks: Does management convey that investors, analysts, or the market at large are still seeing the company through an older or inaccurate lens? I don't see a clear statement to that effect. They don't say "the market still thinks we're a hospital company" or "investors are worried about X but that's no longer the case." They do mention that they are managing inflation, but that's not a stale view. They also mention that they are "not immune" to challenges, which is a response to a potential concern, but not necessarily a correction of a mistaken view. Perhaps the closest is when they talk about the shift to outpatient and that they are capturing that, but that's more of a growth story. I think the answer is NO because management does not explicitly identify a stale or mistaken external view. They are reporting results and providing guidance, but not correcting a misperception. Thus, answer NO.

← Back to the full SGRY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management devote meaningful effort to CORRECTING AN OUT-OF-DATE OR MISTAKEN EXTERNAL PICTURE OF THE COMPANY — that is, does management convey that investors, analysts, or the market at large are still seeing the company through an older or inaccurate lens (about what it sells, who it serves, how it earns, its quality, its risk, or its trajectory), AND does management answer that stale picture with CURRENT, CONCRETE FACTS about the business as it stands today rather than with promises, plans, or reassurance alone? Answer YES when BOTH halves come through in management's own words as one coherent posture, in whatever form fits the business: (1) MANAGEMENT IDENTIFIES A STALE OR MISTAKEN VIEW HELD BY OUTSIDERS. Management indicates — directly or plainly in substance — that some meaningful part of how the company is currently perceived does not match what the company now is. This can take many forms: management saying the market, investors, or analysts still view the company as something it no longer is; pushing back on a persistent concern, label, or assumption it says no longer applies; noting that the company's results, mix, customers, or risk profile are different from what outsiders assume; explaining that a widely held worry is based on an old version of the business; or repeatedly re-framing questions that are premised on the outdated picture. The stale view may concern anything consequential — the business mix, the durability of demand, a past problem assumed to persist, dependence on something the company has moved beyond, or the nature of what the company actually does today. (2) THE CORRECTION RESTS ON PRESENT-TENSE OPERATING SUBSTANCE. Management backs the corrected picture with specific things that are ALREADY TRUE of the current business — actual current customers, volumes, contracts, mix, capabilities, economics, or completed changes it can point to now — so the updated picture is presented as an existing fact being under-recognized, not a future state being promised. The facts offered should be concrete enough that the corrected view stands on what the business is currently doing rather than on management's confidence or vision. Answer NO if the call is ordinary reporting or promotion with no indication that management believes outsiders hold an outdated or mistaken picture. NO if management merely expresses generic frustration that the stock is undervalued or that the market 'doesn't give us credit,' without identifying what specifically is misperceived and answering it with current facts. NO if the corrected picture rests mainly on plans, targets, pipelines, or hoped-for improvements rather than on what is already true. NO if management is chiefly making excuses for weak results, disputing fair criticism of ongoing problems, or promising that things will get better someday. NO if the misperception theme appears only in an analyst's question or characterization that management does not itself take up and answer with substance. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GL Globe Life Inc. Q1 2024 2024-04-23 F
OPAD Offerpad Solutions Inc. Q3 2023 2023-11-01 C
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
IMAX IMAX Corporation Q2 2023 2023-07-26 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
THS TreeHouse Foods, Inc. Q1 2023 2023-05-08 B+
CALX Calix, Inc. Q1 2023 2023-04-20 C+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
WGO Winnebago Industries, Inc. Q1 2023 2022-12-16 D
CTHR Charles & Colvard, Ltd. Q1 2023 2022-11-06 F
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
LIN Linde plc Q2 2022 2022-07-28 B+
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
MGNI Magnite, Inc. Q1 2022 2022-05-04 D
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
VVV Valvoline Inc. Q1 2022 2022-02-09 C+
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
AMC AMC Entertainment Holdings, Inc. Q2 2021 2021-08-09 D
GES Guess?, Inc. Q1 2017 2016-05-25 F

How the model reasoned

DASH · Q3 2023 → YESThe question is whether management is correcting an out-of-date or mistaken external picture of the company with current, concrete facts. YES Tony Xu directly addresses the persistent external perception that the marketplace is "highly discretionary" and sensitive to softening consumer spending (from Nikhil Devnani's question), while also noting the market's concern over headwinds and softening consumer. He counters with concrete current facts: every line of business accelerated in growth and improved unit economics, added selection (over 100,000 stores outside restaurants, nearly half of new customers in convenience/grocery/alcohol come to DoorDash first), cohort performance better than pandemic cohorts, and the business remains a tiny fraction of addressable market (less than double-digit % in U.S. restaurants).
PRPH · Q1 2023 → YESThe question is whether management is correcting an out-of-date or mistaken external picture of the company with current, concrete facts. YES Management explicitly identifies the outdated external lens—viewing ProPhase primarily through its COVID-testing revenue and earnings story—while contrasting it with the current reality of diversified assets already generating value (manufacturing facility at capacity with $25M+ revenue potential next year, Nebula Genomics growing >100% YoY, esophageal cancer 200/200 accurate in testing, full clinical/genomic labs built and validating, $40M+ working capital plus equipment). This is backed by present-tense facts rather than future promises alone. The call devotes substantial time to reframing the company’s current operating picture. The answer is YES.
EXFY · Q2 2022 → YESThe question is whether management is correcting an out-of-date or mistaken external picture of the company with current, concrete facts. YES Management directly addresses the persistent external perception that Expensify is "just like everyone else" in the market (the "what real, like what’s actually different between you guys" question that comes up "pretty much every call"). They correct that view by explaining the company's unique positioning: subscription-first model vs. transaction-only competitors, SMB focus vs. enterprise-only sales, and built-for-volatility strengths (no default spike, daily settlement, stable costs, high-margin recurring revenue).

More from the question bank

Someone else already paid for the growthAhead of their own clockScarcity premium: the thing the company sellReordering the pecking orderProof-point cadenceAlready spoken for downstreamAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.